Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. One study found that under a quarter of children with multi-metastatic Ewing sarcoma ...

The drug pazopanib (Votrient) extended the lives of a small group of kids with Ewing sarcoma, which causes cancerous tumors ...

Shanghai Pharmaceuticals Holding Co Class H (($SHPMF)) announced an update on their ongoing clinical study. Shanghai Pharmaceuticals Holding Co.

Survival rates from small trial suggest that adding pazopanib to standard treatment for Ewing sarcoma in children may extend lives without adding severe toxicity.

Ewing sarcoma is a malignant type of bone tumor, meaning it is a form of cancer that spreads. According to a 2024 review, Ewing sarcoma is the second most common primary cancerous bone tumor. It ...

Ewing sarcoma develops due to genetic causes that include changes to a person’s DNA and chromosomes. It more often affects teenagers and young adults, males, and white people. The exact cause of Ewing ...

Ewing sarcoma is a rare and serious diagnosis, largely impacting children. The disease only accounts for about 1% of all pediatric cancers in the U.S., with about 250 children diagnosed every year, ...

Treatment depends on the sarcoma’s type, location, grade, and stage, as well as the patient’s overall health and goals of care. Many patients benefit from a team approach that includes oncologists, ...

- Company Initiating Planning of Phase 2 Trial of Elraglusib in Children, Adolescents, and Adults with Refractory/Resistant Ewing Sarcoma CHICAGO and FORT WORTH, Texas, July 17, 2025 (GLOBE NEWSWIRE) ...

Kim Fellner enters the waiting area at Sibley Memorial Hospital to receive her third course of radiation treatment for Ewing’s sarcoma. (Candace Dane Chambers/For The Washington Post) Guest column by ...